98%
921
2 minutes
20
Rationale: Cannabis is the most widely used illicit substance in the USA and is often reportedly used for stress reduction. Indeed, cannabinoids modulate signaling of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system. However, the role of biological sex in this interaction between cannabis use and stress is poorly understood, despite sex differences in neurobiological stress responsivity, endocannabinoid signaling, and clinical correlates of cannabis use.
Objective: The study aims to examine the role of biological sex in multisystem stress responsivity in cannabis users.
Methods: Frequent cannabis users (> 3 times/week, n = 48, 52% male) and non-users (n = 41, 49% male) participated in an acute psychosocial stress paradigm. Saliva was collected at eight timepoints and analyzed for hypothalamic-pituitary-adrenal (cortisol) and sympathetic (alpha-amylase) indices of stress responsivity, and basal estradiol. Subjective ratings of negative affect, including distress, were collected at three timepoints.
Results: Cannabis users showed blunted pre-to-post-stress cortisol reactivity. Female cannabis users demonstrated greater blunted cortisol reactivity than their male counterparts. Sex moderated the effect of cannabis use on alpha-amylase responsivity over time, wherein female cannabis users showed flattened alpha-amylase responses across the stressor compared to male cannabis users and both non-user groups. Qualitatively, female cannabis users demonstrated the greatest pre-to-post-stress change in subjective distress. Differences in stress responding were not explained by estradiol or distress intolerance.
Conclusions: Biological sex impacts multisystem stress responding in cannabis users. Paradoxically, female cannabis users showed the least physiological, but greatest subjective, responses to the stressor. Further research into sex differences in the effects of cannabis use is warranted to better understand mechanisms and clinical implications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12247042 | PMC |
http://dx.doi.org/10.1007/s00213-023-06400-z | DOI Listing |
Psychopharmacology (Berl)
September 2025
Center for Medicinal Cannabis Research, Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Rationale: Between periods of use, chronic cannabis consumers may display residual effects on selective cognitive functions, particularly memory and attention. Whether there are comparable deficits in real-world behaviors, such as driving, has not been thoroughly examined.
Objectives: The current study explored the association between driving simulator performance, cannabis use history, and demographic factors after ≥ 48 h of abstinence.
Objective: With the rising misuse of benzodiazepine (BZD) and associated overdose deaths, cannabis has been touted as a potential substitute with proposed benefit of better health outcomes. This two-year retrospective analysis examined whether cannabis use among BZD users was associated with changes in outcomes of (1) all-cause mortality, (2) hospitalizations, (3) emergency department (ED) visits, and (4) whether it demonstrated BZD-sparing effects on prescription quantity over time.
Methods: Using data from Yale New Haven Health System, we conducted a retrospective, longitudinal cohort study among BZD users.
Cannabis
July 2025
Institute for Mental Health Policy and Research (IMHPR), Centre for Addiction and Mental Health (CAMH).
Objective: Legal cannabis dispensary employees ("Budtenders") are a significant resource for cannabis users. Current research indicates that cannabis use may adversely impact mental health. Public perception, however, is often inconsistent with this evidence, leading to increased use and disproportionate harm towards individuals with mental health disorders.
View Article and Find Full Text PDFCannabis
July 2025
TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center.
Objective: Expectancies play a critical role in cannabis use behavior and are influenced by sociodemographic and intrapersonal factors. This study examined daily endorsement of positive and negative cannabis use expectancies using 28 days of ecological momentary assessments (EMAs) in relation to sociodemographics, mental health symptoms, and cannabis use disorder (CUD) among young adult cannabis-tobacco co-users.
Method: Ninety-seven young adult (ages 18-24) cannabis and tobacco co-users reported on anxiety symptoms, depressive symptoms, and possible CUD at baseline.
Public Health
July 2025
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada; British Columbia Centre on Substance Use, Vancouver, BC, Canada. Electronic address:
Objectives: Street sweeps, involving the state-enforced removal of makeshift residences and confiscation of personal belongings from people in public spaces, are a common tool employed by urban governments to address public health and safety concerns. Amidst the ongoing housing and toxic drug poisoning crises in Vancouver, Canada, we sought to characterize experiences of confiscation of personal belongings by city workers among unstably-housed people who use drugs people who use drugs.
Study Design: Cohort study.